Natriuretic Peptides Linked to Lower Risk of Type 2 Diabetes
Researchers sought to discover whether high natriuretic peptides are associated with a lower risk of type 2 diabetes in people with and without cardiovascular disease.
Cardiovascular and Metabolic Disorders
Hormone Therapy Not Tied to T2DM, CV Risk in Postmenopausal Women
Menopausal hormone therapy is not associated with increased risks for cardiovascular disease or type 2 diabetes among middle-aged postmenopausal women.
Ezetimibe Plus Statin Therapy Reduces Post-ACS Cardiovascular Event Risk
Researchers evaluated the association between baseline LDL-C and treatment with ezetimibe plus statins in post-acute coronary syndrome.
Cardiac Events With Type 2 Diabetes, Kidney Disease Reduced With Finerenone
Chronic kidney disease increases the risk of cardiovascular events associated with type 2 diabetes. A clinical trial sought to discover if finerenone would help patients with both of these conditions.
Statin Therapy Decisions by Patients and Doctors Compared By Technology
An online technology was developed to assess whether physicians and potential patients who may benefit from statin therapy would come to the same diagnostic conclusion.
Prognostic Role of NT-proBNP Levels in Empagliflozin-Treated HFrEF
The significance of NT-proBNP levels in empagliflozin-treated chronic HFrEF was evaluated in this study.
Children With Type 2 Diabetes Face Health Challenges in Adulthood
Children diagnosed with type 2 diabetes may face certain health challenges that grow worse over time and follow them into adulthood.
Childhood Body Size May Affect Cardiovascular Disease Outcomes in Adulthood
Larger body size during childhood was found to have direct causal effect on CVD outcomes in adulthood.
Concomitant Elevations in Lipoprotein (a) and High-Sensitivity C-Reactive Protein Increases Risk for CVD, All-Cause Mortality
Individuals with high lipoprotein (a) and concomitant elevated high-sensitivity C-reactive protein (hsCRP) were associated with increased risk for atherosclerosis cardiovascular disease (ASCVD) and all-cause mortality.
Triglyceride-Glucose Index Lacks Predictive Value for Adverse CV Prognosis in Nondiabetic PCI
The triglyceride-glucose index (TyG index) is an ineffective predictive factor for cardiovascular prognosis in patients without diabetes who underwent percutaneous coronary intervention.
- Loading...
Loading...
Next post in Cardiovascular and Metabolic Disorders
Loading... 
Loading...